STAAR Surgical Company (STAA)
USD 24.26
(-4.64%)
USD 24.26
(-4.64%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 102.73 Million USD | 24.22% |
| 2022 | 82.7 Million USD | -5.18% |
| 2021 | 87.22 Million USD | 44.9% |
| 2020 | 60.19 Million USD | 28.12% |
| 2019 | 46.98 Million USD | 34.57% |
| 2018 | 34.91 Million USD | 39.67% |
| 2017 | 24.99 Million USD | -9.23% |
| 2016 | 27.53 Million USD | 14.23% |
| 2015 | 24.1 Million USD | 10.53% |
| 2014 | 21.81 Million USD | -5.49% |
| 2013 | 23.07 Million USD | 0.27% |
| 2012 | 23.01 Million USD | 17.75% |
| 2011 | 19.54 Million USD | 7.66% |
| 2010 | 18.15 Million USD | -51.72% |
| 2009 | 37.61 Million USD | 2.89% |
| 2008 | 36.55 Million USD | 103.6% |
| 2007 | 17.95 Million USD | 12.14% |
| 2006 | 16.01 Million USD | 29.23% |
| 2005 | 12.38 Million USD | -12.2% |
| 2004 | 14.11 Million USD | 19.63% |
| 2003 | 11.79 Million USD | -19.03% |
| 2002 | 14.56 Million USD | -23.23% |
| 2001 | 18.97 Million USD | -11.67% |
| 2000 | 21.48 Million USD | -33.07% |
| 1999 | 32.1 Million USD | 29.96% |
| 1998 | 24.7 Million USD | 40.34% |
| 1997 | 17.6 Million USD | 21.38% |
| 1996 | 14.5 Million USD | 43.56% |
| 1995 | 10.1 Million USD | 46.38% |
| 1994 | 6.9 Million USD | 1.47% |
| 1993 | 6.8 Million USD | 23.64% |
| 1992 | 5.5 Million USD | 7.84% |
| 1991 | 5.1 Million USD | -51.43% |
| 1990 | 10.5 Million USD | -50.7% |
| 1989 | 21.3 Million USD | 5.97% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 109.46 Million USD | 5.62% |
| 2024 Q2 | 103.64 Million USD | 3.9% |
| 2024 Q1 | 99.74 Million USD | -2.91% |
| 2023 Q4 | 102.73 Million USD | 10.56% |
| 2023 FY | 102.73 Million USD | 24.22% |
| 2023 Q3 | 92.92 Million USD | 6.87% |
| 2023 Q2 | 86.95 Million USD | 8.72% |
| 2023 Q1 | 79.98 Million USD | -3.29% |
| 2022 Q3 | 74.54 Million USD | -2.83% |
| 2022 Q2 | 76.71 Million USD | 2.48% |
| 2022 Q4 | 82.7 Million USD | 10.95% |
| 2022 Q1 | 74.86 Million USD | -14.17% |
| 2022 FY | 82.7 Million USD | -5.18% |
| 2021 Q4 | 87.22 Million USD | 15.53% |
| 2021 FY | 87.22 Million USD | 44.9% |
| 2021 Q1 | 51.63 Million USD | -14.23% |
| 2021 Q2 | 59.81 Million USD | 15.86% |
| 2021 Q3 | 75.49 Million USD | 26.22% |
| 2020 FY | 60.19 Million USD | 28.12% |
| 2020 Q4 | 60.19 Million USD | 24.61% |
| 2020 Q3 | 48.3 Million USD | 11.39% |
| 2020 Q2 | 43.36 Million USD | 3.69% |
| 2020 Q1 | 41.82 Million USD | -10.98% |
| 2019 Q4 | 46.98 Million USD | 8.25% |
| 2019 FY | 46.98 Million USD | 34.57% |
| 2019 Q2 | 41.62 Million USD | 4.38% |
| 2019 Q3 | 43.4 Million USD | 4.26% |
| 2019 Q1 | 39.88 Million USD | 14.23% |
| 2018 Q4 | 34.91 Million USD | 2.31% |
| 2018 Q1 | 32.37 Million USD | 29.52% |
| 2018 FY | 34.91 Million USD | 39.67% |
| 2018 Q2 | 31.62 Million USD | -2.31% |
| 2018 Q3 | 34.12 Million USD | 7.9% |
| 2017 Q1 | 28.47 Million USD | 3.41% |
| 2017 Q2 | 25.34 Million USD | -11.01% |
| 2017 Q3 | 32.04 Million USD | 26.43% |
| 2017 FY | 24.99 Million USD | -9.23% |
| 2017 Q4 | 24.99 Million USD | -21.99% |
| 2016 FY | 27.53 Million USD | 14.23% |
| 2016 Q3 | 28.6 Million USD | 4.72% |
| 2016 Q2 | 27.31 Million USD | 15.99% |
| 2016 Q1 | 23.54 Million USD | -2.32% |
| 2016 Q4 | 27.53 Million USD | -3.73% |
| 2015 Q4 | 24.1 Million USD | 7.76% |
| 2015 FY | 24.1 Million USD | 10.53% |
| 2015 Q1 | 20.46 Million USD | -6.2% |
| 2015 Q2 | 20.5 Million USD | 0.22% |
| 2015 Q3 | 22.37 Million USD | 9.1% |
| 2014 Q2 | 22.54 Million USD | -2.21% |
| 2014 Q1 | 23.05 Million USD | -0.13% |
| 2014 FY | 21.81 Million USD | -5.49% |
| 2014 Q4 | 21.81 Million USD | -1.53% |
| 2014 Q3 | 22.15 Million USD | -1.73% |
| 2013 Q3 | 21.71 Million USD | 8.55% |
| 2013 Q1 | 20 Million USD | -13.07% |
| 2013 FY | 23.07 Million USD | 0.27% |
| 2013 Q4 | 23.07 Million USD | 6.28% |
| 2013 Q2 | 20 Million USD | -0.02% |
| 2012 Q2 | 18.35 Million USD | 3.74% |
| 2012 Q3 | 19.21 Million USD | 4.66% |
| 2012 Q4 | 23.01 Million USD | 19.79% |
| 2012 FY | 23.01 Million USD | 17.75% |
| 2012 Q1 | 17.69 Million USD | -9.47% |
| 2011 FY | 19.54 Million USD | 7.66% |
| 2011 Q3 | 17.52 Million USD | 2.48% |
| 2011 Q2 | 17.09 Million USD | 1.8% |
| 2011 Q1 | 16.79 Million USD | -7.52% |
| 2011 Q4 | 19.54 Million USD | 11.58% |
| 2010 FY | 18.15 Million USD | -51.72% |
| 2010 Q4 | 18.15 Million USD | 7.37% |
| 2010 Q1 | 31.85 Million USD | -15.32% |
| 2010 Q2 | 15.67 Million USD | -50.78% |
| 2010 Q3 | 16.91 Million USD | 7.88% |
| 2009 Q1 | 35.46 Million USD | -2.99% |
| 2009 Q2 | 36.04 Million USD | 1.64% |
| 2009 FY | 37.61 Million USD | 2.89% |
| 2009 Q4 | 37.61 Million USD | 2.32% |
| 2009 Q3 | 36.76 Million USD | 1.99% |
| 2008 Q2 | 31.86 Million USD | -2.99% |
| 2008 Q1 | 32.84 Million USD | 82.95% |
| 2008 FY | 36.55 Million USD | 103.6% |
| 2008 Q4 | 36.55 Million USD | 18.4% |
| 2008 Q3 | 30.87 Million USD | -3.11% |
| 2007 Q1 | 20.88 Million USD | 30.43% |
| 2007 FY | 17.95 Million USD | 12.14% |
| 2007 Q4 | 17.95 Million USD | 19.27% |
| 2007 Q3 | 15.05 Million USD | 4.57% |
| 2007 Q2 | 14.39 Million USD | -31.07% |
| 2006 FY | 16.01 Million USD | 29.23% |
| 2006 Q3 | 13.26 Million USD | 2.81% |
| 2006 Q4 | 16.01 Million USD | 20.72% |
| 2006 Q2 | 12.9 Million USD | 6.09% |
| 2006 Q1 | 12.15 Million USD | -1.86% |
| 2005 Q3 | 11.44 Million USD | 2.15% |
| 2005 Q1 | 12.1 Million USD | -14.24% |
| 2005 FY | 12.38 Million USD | -12.2% |
| 2005 Q2 | 11.2 Million USD | -7.38% |
| 2005 Q4 | 12.38 Million USD | 8.21% |
| 2004 Q4 | 14.11 Million USD | 11.69% |
| 2004 FY | 14.11 Million USD | 19.63% |
| 2004 Q1 | 11.58 Million USD | -1.82% |
| 2004 Q2 | 13.23 Million USD | 14.26% |
| 2004 Q3 | 12.63 Million USD | -4.52% |
| 2003 FY | 11.79 Million USD | -19.03% |
| 2003 Q4 | 11.79 Million USD | -7.63% |
| 2003 Q3 | 12.77 Million USD | 3.1% |
| 2003 Q2 | 12.38 Million USD | -17.56% |
| 2003 Q1 | 15.02 Million USD | 3.14% |
| 2002 Q3 | 16.65 Million USD | -10.69% |
| 2002 Q2 | 18.64 Million USD | 4.18% |
| 2002 Q1 | 17.89 Million USD | -5.68% |
| 2002 Q4 | 14.56 Million USD | -12.52% |
| 2002 FY | 14.56 Million USD | -23.23% |
| 2001 FY | 18.97 Million USD | -11.67% |
| 2001 Q1 | 21.38 Million USD | -0.44% |
| 2001 Q2 | 21.97 Million USD | 2.74% |
| 2001 Q4 | 18.97 Million USD | -8.35% |
| 2001 Q3 | 20.7 Million USD | -5.78% |
| 2000 Q3 | 40.24 Million USD | -0.2% |
| 2000 FY | 21.48 Million USD | -33.07% |
| 2000 Q1 | 36.08 Million USD | 12.42% |
| 2000 Q4 | 21.48 Million USD | -46.62% |
| 2000 Q2 | 40.32 Million USD | 11.75% |
| 1999 Q3 | 27.9 Million USD | 11.16% |
| 1999 Q2 | 25.1 Million USD | 3.72% |
| 1999 Q1 | 24.2 Million USD | -2.02% |
| 1999 FY | 32.1 Million USD | 29.96% |
| 1999 Q4 | 32.1 Million USD | 15.05% |
| 1998 FY | 24.7 Million USD | 40.34% |
| 1998 Q3 | 22.7 Million USD | -2.16% |
| 1998 Q4 | 24.7 Million USD | 8.81% |
| 1998 Q1 | 22.5 Million USD | 27.84% |
| 1998 Q2 | 23.2 Million USD | 3.11% |
| 1997 FY | 17.6 Million USD | 21.38% |
| 1997 Q1 | 11.5 Million USD | -20.69% |
| 1997 Q2 | 12.2 Million USD | 6.09% |
| 1997 Q3 | 10.7 Million USD | -12.3% |
| 1997 Q4 | 17.6 Million USD | 64.49% |
| 1996 Q3 | 15.4 Million USD | 27.27% |
| 1996 Q1 | 11.6 Million USD | 14.85% |
| 1996 FY | 14.5 Million USD | 43.56% |
| 1996 Q4 | 14.5 Million USD | -5.84% |
| 1996 Q2 | 12.1 Million USD | 4.31% |
| 1995 Q2 | 8.5 Million USD | 19.72% |
| 1995 Q4 | 10.1 Million USD | 21.69% |
| 1995 FY | 10.1 Million USD | 46.38% |
| 1995 Q1 | 7.1 Million USD | 2.9% |
| 1995 Q3 | 8.3 Million USD | -2.35% |
| 1994 Q3 | 5.4 Million USD | -3.57% |
| 1994 Q1 | 5.6 Million USD | -17.65% |
| 1994 Q2 | 5.6 Million USD | 0.0% |
| 1994 FY | 6.9 Million USD | 1.47% |
| 1994 Q4 | 6.9 Million USD | 27.78% |
| 1993 Q2 | 5.6 Million USD | 0.0% |
| 1993 FY | 6.8 Million USD | 23.64% |
| 1993 Q4 | 6.8 Million USD | 33.33% |
| 1993 Q3 | 5.1 Million USD | -8.93% |
| 1992 Q4 | 5.5 Million USD | 0.0% |
| 1992 FY | 5.5 Million USD | 7.84% |
| 1991 Q4 | 5.1 Million USD | 0.0% |
| 1991 Q1 | 10.3 Million USD | -1.9% |
| 1991 FY | 5.1 Million USD | -51.43% |
| 1990 FY | 10.5 Million USD | -50.7% |
| 1990 Q4 | 10.5 Million USD | 0.0% |
| 1989 FY | 21.3 Million USD | 5.97% |
| 1989 Q4 | 21.3 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 126.59 Million USD | 18.848% |
| AngioDynamics, Inc. | 112.08 Million USD | 8.339% |
| AtriCure, Inc. | 147.76 Million USD | 30.472% |
| Avinger, Inc. | 19.97 Million USD | -414.41% |
| Azenta, Inc. | 351.22 Million USD | 70.748% |
| BioLife Solutions, Inc. | 75.05 Million USD | -36.891% |
| The Cooper Companies, Inc. | 4.1 Billion USD | 97.499% |
| Daxor Corporation | 858.75 Thousand USD | -11863.557% |
| Ekso Bionics Holdings, Inc. | 16.31 Million USD | -529.831% |
| Femasys Inc. | 9.4 Million USD | -992.581% |
| GlucoTrack, Inc. | 1.7 Million USD | -5915.105% |
| Harvard Bioscience, Inc. | 64.29 Million USD | -59.799% |
| Hologic, Inc. | 4.02 Billion USD | 97.448% |
| ICU Medical, Inc. | 2.25 Billion USD | 95.444% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | 94.974% |
| KORU Medical Systems, Inc. | 8.1 Million USD | -1167.244% |
| LeMaitre Vascular, Inc. | 48.87 Million USD | -110.193% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -15467.873% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -15467.873% |
| Masimo Corporation | 1.67 Billion USD | 93.873% |
| Microbot Medical Inc. | 3.82 Million USD | -2585.259% |
| Meihua International Medical Technologies Co., Ltd. | 25.07 Million USD | -309.683% |
| Merit Medical Systems, Inc. | 1.12 Billion USD | 90.853% |
| Nephros, Inc. | 3.5 Million USD | -2832.858% |
| NovoCure Limited | 783.63 Million USD | 86.89% |
| NEXGEL, Inc. | 4.78 Million USD | -2045.291% |
| NEXGEL, Inc. | 4.78 Million USD | -2045.291% |
| Singular Genomics Systems, Inc. | 86.46 Million USD | -18.826% |
| OraSure Technologies, Inc. | 52.17 Million USD | -96.914% |
| Pro-Dex, Inc. | 23.34 Million USD | -340.123% |
| Pulse Biosciences, Inc. | 16.44 Million USD | -524.775% |
| Predictive Oncology Inc. | 6.14 Million USD | -1571.768% |
| Precision Optics Corporation, Inc. | 6.84 Million USD | -1400.967% |
| QuidelOrtho Corporation | 3.55 Billion USD | 97.112% |
| Repligen Corporation | 853.2 Million USD | 87.959% |
| Sanara MedTech Inc. | 29.28 Million USD | -250.844% |
| Sharps Technology, Inc. | 3.85 Million USD | -2565.071% |
| Utah Medical Products, Inc. | 7.14 Million USD | -1337.901% |
| DENTSPLY SIRONA Inc. | 4.07 Billion USD | 97.479% |
| Jin Medical International Ltd. | 8.92 Million USD | -1051.211% |